Literature DB >> 16086894

Risk of travel-associated typhoid and paratyphoid fevers in various regions.

Karl Ekdahl1, Birgitta de Jong, Yvonne Andersson.   

Abstract

BACKGROUND: Although enteric fever (typhoid and paratyphoid fevers) is a major global public health problem, comparable data on the risks of contracting travel-associated enteric fever in various regions of the world are scarce.
METHODS: From the Swedish database on notifiable communicable diseases, we retrieved all case records from 1997 to 2003 on typhoid and paratyphoid fevers. The data set was compared with data on travel patterns obtained from a comprehensive travel database with information from interviews with more than 16,000 Swedish residents with recent overnight travel outside Sweden.
RESULTS: The overall risk of being notified with enteric fever after travel was 0.42 in 100,000 travelers. The highest risk for typhoid fever was seen in travelers from India and neighboring countries (41.7 in 100,000), the Middle East (5.91 in 100,000), and Central Africa (3.33 in 100,000), whereas the risk was comparatively low in East Asia (0.24 in 100,000). Almost the same risk areas stood out for paratyphoid fever: India and neighbors (37.5 in 100,000), the Middle East (3.64 in 100,000), and East Africa (3.33 in 100,000). The epidemiology of paratyphoid fever was considerably affected by a large outbreak of paratyphoid B in a Turkish tourist resort in 1999. The youngest children were at highest risk for typhoid fever (odds ratio 44.2), whereas youths ages 7 to 18 years were at highest risk for paratyphoid fever (odds ratio 9.7).
CONCLUSIONS: Detailed risk data for enteric fever after travel could form the basis for travel advice. Vaccination against typhoid fever should always be considered for travelers to the Indian subcontinent, the Middle East, and Africa but should not routinely be given to travelers to the Malay Peninsula.

Entities:  

Mesh:

Year:  2005        PMID: 16086894     DOI: 10.2310/7060.2005.12405

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  17 in total

1.  Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia.

Authors:  I Ratnam; J Black; K Leder; B-A Biggs; E Matchett; A Padiglione; I Woolley; T Panagiotidis; T Gherardin; L Pollissard; C Demont; C Luxemburger; J Torresi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

2.  Epidemiology of enteric disease in C-EnterNet's pilot site - Waterloo region, Ontario, 1990 to 2004.

Authors:  Victoria A Keegan; Shannon E Majowicz; David L Pearl; Barbara J Marshall; Nancy Sittler; Lewinda Knowles; Jeffery B Wilson
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

Authors:  S Kuhn; C Hui
Journal:  Can Commun Dis Rep       Date:  2010-06-10

4.  Imported enteric fever: case series from the hospital for tropical diseases, London, United Kingdom.

Authors:  Trupti A Patel; Margaret Armstrong; Stephen D Morris-Jones; Stephen G Wright; Tom Doherty
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

5.  Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience.

Authors:  S Hume; T Schulz; P Vinton; T Korman; J Torresi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-09       Impact factor: 3.267

6.  President's address: travel medicine and principles of safe travel.

Authors:  Herbert L DuPont
Journal:  Trans Am Clin Climatol Assoc       Date:  2008

7.  Impact of Temperature and Rainfall on Typhoid/Paratyphoid Fever in Taizhou, China: Effect Estimation and Vulnerable Group Identification.

Authors:  Qi Gao; Zhidong Liu; Jianjun Xiang; Ying Zhang; Michael Xiaoliang Tong; Shuzi Wang; Yiwen Zhang; Qiyong Liu; Baofa Jiang; Peng Bi
Journal:  Am J Trop Med Hyg       Date:  2021-12-06       Impact factor: 2.345

8.  O:2-CRM(197) conjugates against Salmonella Paratyphi A.

Authors:  Francesca Micoli; Simona Rondini; Massimiliano Gavini; Luisa Lanzilao; Donata Medaglini; Allan Saul; Laura B Martin
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  International travel and the risk of hospitalization with non-typhoidal Salmonella bacteremia. A Danish population-based cohort study, 1999-2008.

Authors:  Kristoffer Koch; Brian Kristensen; Hanne M Holt; Steen Ethelberg; Kåre Mølbak; Henrik C Schønheyder
Journal:  BMC Infect Dis       Date:  2011-10-19       Impact factor: 3.090

10.  Risk for travel-associated legionnaires' disease, Europe, 2009.

Authors:  Julien Beauté; Phillip Zucs; Birgitta de Jong
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.